Real-time Estimate
Cboe BZX
02:18:01 2024-05-09 pm EDT
5-day change
1st Jan Change
150
USD
-0.51%
+2.82%
+21.37%
Presentation Operator MessageOperator (Operator)Ladies and gentlemen, thank you for standing ...
This article is reserved for subscribers
Signed up already?
Log In Not subscribed yet?
Subscribe
Aptargroup Insider Sold Shares Worth $672,344, According to a Recent SEC Filing
May. 01
MT
North American Morning Briefing : More Earnings -2-
Apr. 30
DJ
Baird Adjusts Price Target on AptarGroup to $170 From $150, Maintains Outperform Rating
Apr. 29
MT
William Blair Upgrades AptarGroup to Outperform From Market Perform
Apr. 29
MT
Tranche Update on AptarGroup, Inc.'s Equity Buyback Plan announced on April 18, 2019.
Apr. 26
CI
Transcript : AptarGroup, Inc., Q1 2024 Earnings Call, Apr 26, 2024
Apr. 26
AptarGroup Q1 Adjusted Earnings, Sales Rise; Sets Q2 EPS Guidance
Apr. 25
MT
Aptargroup, Inc. Provides Earnings Guidance for the Second Quarter of 2024
Apr. 25
CI
Aptargroup, Inc. Approves Quarterly Dividend, Payable on May 16, 2024
Apr. 25
CI
AptarGroup, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Apr. 25
CI
Earnings Flash (ATR) APTARGROUP Posts Q1 Revenue $915.4M, vs. Street Est of $890.9M
Apr. 25
MT
Earnings Flash (ATR) APTARGROUP Reports Q1 EPS $1.26, vs. Street Est of $1.15
Apr. 25
MT
AptarGroup Keeps Quarterly Cash Dividend at $0.41 a Share, Payable May 16 to Holders of Record April 25
Apr. 11
MT
AptarGroup, Inc. Declares Quarterly Dividend, Payable on May 16, 2024
Apr. 11
CI
Aptargroup Insider Sold Shares Worth $284,906, According to a Recent SEC Filing
Mar. 12
MT
Aptargroup Insider Sold Shares Worth $499,932, According to a Recent SEC Filing
Mar. 12
MT
Wells Fargo Adjusts AptarGroup's Price Target to $160 From $157, Maintains Overweight Rating
Mar. 07
MT
Aptargroup Insider Sold Shares Worth $4,533,394, According to a Recent SEC Filing
Mar. 05
MT
Tanda, CEO of Aptar: Inflation less of a concern in the pharmaceutical sector
Feb. 12
MT
AptarGroup's Digital Health Business, Biogen to Develop Products for Neurological, Rare Diseases
Feb. 09
MT
Sector Update: Health Care Stocks Mixed Pre-Bell Friday
Feb. 09
MT
Transcript : AptarGroup, Inc., Q4 2023 Earnings Call, Feb 09, 2024
Feb. 09
AptarGroup Q4 Adjusted Earnings, Sales Rise; Sets Q1 Outlook
Feb. 08
MT
Earnings Flash (ATR) APTARGROUP Posts Q4 Revenue $838.5M, vs. Street Est of $842.5M
Feb. 08
MT
Earnings Flash (ATR) APTARGROUP Posts Q4 EPS $1.21, vs. Street Est of $1.12
Feb. 08
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
More about the company
Last Close Price
150.8
USD
Average target price
155
USD
Spread / Average Target
+2.79%
Consensus
1st Jan change
Capi.
+21.37% 9.99B +6.59% 14.76B -11.52% 7.1B +36.80% 1.52B +15.22% 1.45B -12.23% 1.37B +34.47% 1.29B -18.62% 1.06B +23.11% 854M +43.75% 735M
Plastic Containers & Packaging
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1